Latest Shareholder Approval News

Canterbury Resources enters FY2027 with just $220,503 in cash, net current liabilities and an auditor-highlighted material uncertainty over its ability to continue as a going concern. The explorer is targeting at least $2 million in additional funding while advancing the Monto and Briggs copper projects.

Eminence Minerals has cut its FY2026 loss and raised its pro forma cash position to about A$5.4 million after selling the Mata da Corda titanium project. The portfolio is now centred on Hamersley iron ore and Brazilian rare earth exploration, but heritage litigation, ungranted tenure and future funding needs remain material constraints.

Blaze Minerals reported a narrower FY2026 loss, but ended the year with just $43,552 in cash and an auditor-highlighted material uncertainty over its ability to continue as a going concern. The company is relying on shareholder-approved funding, a proposed 20:1 consolidation and a conditional Ugandan tungsten acquisition to reshape its next phase.

VBX has expanded the Wuudagu Bauxite Project’s resource to 143.2 million tonnes, but its FY26 accounts expose acute funding pressure, with just $301,208 in cash and an auditor warning of material uncertainty over going concern. The definitive feasibility study has been pushed into the first quarter of 2027 while the company relies on fresh equity, related-party funding and prospective strategic partners.

Australian Gold and Copper expanded its exploration footprint and advanced major targets during FY2026, but the campaign came with a larger loss and a sharp reduction in cash. The company now has a 38.5Moz silver-equivalent Achilles resource, a newly acquired Junee gold portfolio and further funding demands ahead.

Solara Minerals has reported a sharply wider FY2026 loss after impairing $3.14 million of exploration assets, while cash fell to $2.03 million. The early-stage explorer expanded its Bryah Basin portfolio but says further funding may be needed to continue exploration.

Tennant Minerals has reported a high-grade maiden resource and further strong drilling at its Bluebird copper-gold discovery, but the annual report carries a material uncertainty over the company’s ability to continue as a going concern. A $2.8 million capital raise completed around year-end provides near-term funding, while further exploration and processing studies remain ahead.

oOh!media’s $1.68-per-share takeover by I Squared Capital has cleared another formal milestone, with the scheme booklet now registered by ASIC. The independent expert considers the offer fair and reasonable, but shareholders must still vote before the proposed 26 November implementation.

Memphasys will receive an A$3.5 million advance from major shareholder Peters Investments to expand Felix production, inventory and sales capacity as repeat orders emerge across international markets. The funding carries a 12.5% interest rate, potential equity dilution and requires shareholder and ASX approvals before the convertible notes can be issued.

Argent BioPharma has secured exclusive commercialisation rights to selected Tollovir, Tollovid and NutraVir antiviral products in a worldwide deal excluding China. The agreement adds a new commercial pillar alongside CimetrA®, but does not itself grant pharmaceutical development rights or establish clinical efficacy.

Tungsten Mining says non-binding debt proposals could fund up to 70% of its Watershed project, equivalent to about A$200 million against estimated pre-production capital of A$274 million. The financing remains uncommitted, with strategic investment, offtake and government-backed options still in play.

Asara Resources has emerged from FY2026 with a substantially larger Kada gold resource, strong cash backing and a more concentrated Guinea strategy. The headline resource update came after year-end and remains a Mineral Resource, not an Ore Reserve or economic mine plan.